Leverage compliance to minimize supply chain threats, maximize operational performance.

Product counterfeiting and diversion are among the biggest threats facing both pharmaceutical brands and patient safety today. Supply chain criminals are stealing more than $200 billion in revenue from the industry each year. What’s worse, when fake drugs hit the market the results are lethal. 

To tackle these threats, companies need to ensure smooth operations on the packaging line, use data to guide strategic decision-making across the supply chain and build stronger brand protection in the marketplace. This requires real-time abilities to discover and mitigate issues.

In this exclusive webinar, brand protection experts from Systech and Johnson & Johnson will share best practices on how to achieve an intelligent supply chain. Get an inside view into what J&J is doing to proactively protect products and patients from increasing levels of risk. All of this founded on making the most of your investment in serialization compliance.

In this informative session you’ll learn:

  • How to gather actionable risk intelligence from operational data.

  • Techniques to strategically identify trends and potential threats in the market.

  • The impact of intelligent and connected packaging.

  • How to build in layers of security with end-to-end visibility.

  • Best practices to protect your brand and ensure safe and secure supply.

Date | On-Demand
Duration | 45 Minutes

Watch "Intelligent Supply Chain: Best Practices to Protect Products and Patients"


steve-tallantSteve Tallant
Senior Director, Market Development, Systech

Steve is a brand marketing and product management expert with over 25 years of experience. He’s worked in a myriad of vertical industries with enabling technologies including anti-counterfeiting, supply chain and product lifecycle management. As a thought leader, Steve has written several white papers and is a frequent contributor of content to global industry publications across pharmaceutical and consumer packaged goods industries. His specialty areas include supply chain security, traceability, blockchain and brand/consumer protection.


david-yingling-b&wDavid Yingling
Brand Protection and Product Security, Johnson & Johnson

David is a senior manager focused on product security at Johnson & Johnson based in Raritan, New Jersey. His role involves protecting J&J brands from illicit activity and working to enhance supply chain security. David has been with the company for 12 years and is currently developing new innovative strategies that center on disruptive technology and putting the customer first. He works to deliver high-value digital solutions that solve business problems and drive growth for J&J.


Dr-Mark-WillisDr. Mark Willis
Willis QS Consulting

Mark is a seasoned pharmaceuticals and medical device professional with more than 20 years’ experience in the industry. He has experience leading global regulatory programs as both a project manager (PMP) and as a software quality engineer participant (certified SQE and Quality Auditor).  With a doctorate in law and public policy, as well as a participant in the construction of the recent ISO 9001 update, Mark has provided consultation on how to “right size” an organization's regulatory compliance so that its software implementations are able to meet its needs without distracting from daily operations. As a professor at Northeastern University, Bunker Hill College, and Massachusetts College of Pharmacy and Health Sciences (MCPHS), 
Mark currently works with global health authority agencies, as well as the UN and USAID to conduct research for technological solutions such as Blockchain and PCIDs to secure the pharmaceutical supply chain and is the author of Counterfeit Pharmaceuticals: Are the U.S. Consumers Aware of the Potential Risks?


Originally aired 2/27/20.